A marked upregulation of CD44 expression has been detected in tumors originating from astrocytes (gliomas) and oligodendrocytes (oligodendrogliomas), in line with the widely described expression of CD44 in neoplasms [70,71]. The gene discussed is CD44; the disease is glioma.